Clinical Trial Update: Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

View source ↗

Summary

A post-marketing surveillance trial of Cervarix conducted in healthy females in Sri Lanka has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Human Papillomavirus Infection | Status: WITHDRAWN